Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dichloroethane | decreases expression | ISO | Bend6 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of BEND6 mRNA | CTD | PMID:28960355 | 17beta-estradiol | multiple interactions | ISO | BEND6 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of BEND6 mRNA | CTD | PMID:20660070 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Bend6 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BEND6 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of BEND6 mRNA | CTD | PMID:32109520 | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:26705709 | 4,4'-sulfonyldiphenol | increases methylation | ISO | BEND6 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of BEND6 gene | CTD | PMID:31601247 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of BEND6 mRNA | CTD | PMID:24780913 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of BEND6 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of BEND6 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases methylation | ISO | BEND6 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of BEND6 gene | CTD | PMID:27153756 | aflatoxin B1 | increases methylation | ISO | BEND6 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of BEND6 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of BEND6 mRNA | CTD | PMID:33167477 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of BEND6 gene | CTD | PMID:35440735 | benzo[a]pyrene | affects methylation | ISO | BEND6 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of BEND6 promoter | CTD | PMID:27901495 | bis(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA | CTD | PMID:31199487 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of BEND6 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | Bend6 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of BEND6 mRNA | CTD | PMID:32156529 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of BEND6 mRNA | CTD | PMID:34947998 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of BEND6 gene | CTD | PMID:28505145 | butanal | decreases expression | ISO | BEND6 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of BEND6 mRNA | CTD | PMID:26079696 | Butylbenzyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA | CTD | PMID:31199487 | chloroacetaldehyde | decreases expression | ISO | BEND6 (Homo sapiens) | 6480464 | chloroacetaldehyde results in decreased expression of BEND6 mRNA | CTD | PMID:25596134 | cisplatin | decreases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of BEND6 mRNA | CTD | PMID:25596134 and PMID:27392435 | cyclosporin A | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of BEND6 mRNA | CTD | PMID:25596134 | cyclosporin A | increases methylation | ISO | BEND6 (Homo sapiens) | 6480464 | Cyclosporine results in increased methylation of BEND6 promoter | CTD | PMID:27989131 | dibutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA | CTD | PMID:31199487 | diethyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA | CTD | PMID:31199487 | diisobutyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA | CTD | PMID:31199487 | diisononyl phthalate | multiple interactions | EXP | | 6480464 | [diethyl phthalate co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate co-treated with diisononyl phthalate co-treated with diisobutyl phthalate co-treated with butylbenzyl phthalate] results in decreased expression of BEND6 mRNA | CTD | PMID:31199487 | dimethyl sulfoxide | affects expression | ISO | BEND6 (Homo sapiens) | 6480464 | Dimethyl Sulfoxide affects the expression of BEND6 mRNA | CTD | PMID:24834073 | dioxygen | decreases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Oxygen deficiency results in decreased expression of BEND6 mRNA | CTD | PMID:25596134 | dorsomorphin | multiple interactions | ISO | BEND6 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | entinostat | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | entinostat results in increased expression of BEND6 mRNA | CTD | PMID:27188386 | lead(0) | affects expression | ISO | BEND6 (Homo sapiens) | 6480464 | Lead affects the expression of BEND6 mRNA | CTD | PMID:28903495 | mercury dibromide | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of BEND6 mRNA | CTD | PMID:26272509 | mercury dibromide | multiple interactions | ISO | BEND6 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEND6 mRNA | CTD | PMID:27188386 | methylmercury chloride | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of BEND6 mRNA | CTD | PMID:28001369 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of BEND6 mRNA | CTD | PMID:33484710 | p-chloromercuribenzoic acid | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of BEND6 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | BEND6 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEND6 mRNA | CTD | PMID:27188386 | phenylmercury acetate | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of BEND6 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | BEND6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEND6 mRNA | CTD | PMID:27188386 | progesterone | multiple interactions | ISO | BEND6 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of BEND6 mRNA | CTD | PMID:20660070 | rotenone | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Rotenone results in increased expression of BEND6 mRNA | CTD | PMID:29955902 | SB 431542 | multiple interactions | ISO | BEND6 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of BEND6 mRNA | CTD | PMID:25895662 | sodium arsenite | increases expression | ISO | Bend6 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of BEND6 mRNA | CTD | PMID:25270620 | sodium arsenite | affects expression | ISO | BEND6 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of BEND6 mRNA | CTD | PMID:34032870 | sulforaphane | increases expression | ISO | Bend6 (Mus musculus) | 6480464 | sulforaphane results in increased expression of BEND6 mRNA | CTD | PMID:30529165 | temozolomide | decreases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of BEND6 mRNA | CTD | PMID:31758290 | thapsigargin | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Thapsigargin results in increased expression of BEND6 mRNA | CTD | PMID:22378314 | titanium dioxide | decreases expression | ISO | Bend6 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of BEND6 mRNA | CTD | PMID:29264374 | trichostatin A | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of BEND6 mRNA | CTD | PMID:27188386 | trovafloxacin | decreases expression | ISO | Bend6 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of BEND6 mRNA | CTD | PMID:35537566 | tunicamycin | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of BEND6 mRNA | CTD | PMID:22378314 | valproic acid | decreases methylation | ISO | BEND6 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of BEND6 gene | CTD | PMID:29154799 | valproic acid | affects expression | ISO | BEND6 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of BEND6 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of BEND6 mRNA | CTD | PMID:19101580 more ... | valproic acid | multiple interactions | ISO | BEND6 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BEND6 mRNA | CTD | PMID:27188386 | vorinostat | increases expression | ISO | BEND6 (Homo sapiens) | 6480464 | vorinostat results in increased expression of BEND6 mRNA | CTD | PMID:27188386 | |